Breaking News Instant updates and real-time market news.

MRNA

Moderna

$122.11 /

-0.035 (-0.03%)

08:18
09/29/22
09/29
08:18
09/29/22
08:18

Moderna appoints Juan Andres to new role, hires Jerh Collins to succeed

Moderna announced that the company has expanded the Executive Committee to "prepare for multiple upcoming new product launches." Effective January 1, 2023, Juan Andres will step into a new role as President, Strategic Partnerships and Enterprise Expansion, and will focus on building out the organization to support the growing pipeline. In this role, he will continue to serve on the Executive Committee and report to CEO Stephane Bancel. Dr. Jerh Collins, Ph.D. will join the company as Chief Technical Operations and Quality Officer, succeeding Mr. Andres. Dr. Collins will join Moderna on October 3, 2022 and will assume the role of Chief Technical Operations and Quality Officer on January 1, 2023. Dr. Collins will serve on Moderna's Executive Committee and report to Bancel. "Juan Andres has been an incredible partner in leading Moderna's manufacturing operations over the last several years, and he has played a crucial role in our COVID-19 vaccine production efforts, protecting and saving hundreds of millions of lives. I am very pleased that Juan will apply his leadership and experience to allow Moderna to scale in its next phase of growth. Juan's continued leadership will be critical as we prepare for several upcoming new product launches," said Moderna CEO Stephane Bancel.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Ingredion gets SBTi approval of its greenhouse gas emissions reduction targets » 08:21
12/01/22
12/01
08:21
12/01/22
08:21
INGR

Ingredion

$97.92 /

+0.875 (+0.90%)

Ingredion announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INGR Ingredion
$97.92 /

+0.875 (+0.90%)

INGR Ingredion
$97.92 /

+0.875 (+0.90%)

11/07/22 Credit Suisse
Ingredion price target raised to $100 from $94 at Credit Suisse
09/30/22 UBS
Ingredion initiated with a Neutral at UBS
04/12/22 Credit Suisse
Ingredion downgraded to Neutral from Outperform at Credit Suisse
INGR Ingredion
$97.92 /

+0.875 (+0.90%)

INGR Ingredion
$97.92 /

+0.875 (+0.90%)

Hot Stocks
Mayfair reports eighth set of drilling results for 2022 from Fenn-Gib expansion » 08:19
12/01/22
12/01
08:19
12/01/22
08:19
MFGCF

Mayfair Gold

/

+

Mayfair Gold announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MFGCF Mayfair Gold
/

+

Hot Stocks
First Quantum agrees to convert ZCCM-IH dividend rights to 3.1% revenue royalty » 08:19
12/01/22
12/01
08:19
12/01/22
08:19
FQVLF

First Quantum Minerals

$23.75 /

+0.67 (+2.90%)

First Quantum Minerals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FQVLF First Quantum Minerals
$23.75 /

+0.67 (+2.90%)

FQVLF First Quantum Minerals
$23.75 /

+0.67 (+2.90%)

11/23/22 Deutsche Bank
First Quantum Minerals price target raised to C$36 from C$28 at Deutsche Bank
11/23/22 Raymond James
First Quantum downgraded to Market Perform from Outperform at Raymond James
11/11/22 JPMorgan
First Quantum Minerals downgraded to Underweight from Overweight at JPMorgan
10/27/22 National Bank
First Quantum Minerals price target lowered to C$30 from C$32 at National Bank
Hot Stocks
Voip-Pal.com announces termination of all Alice 101 motions in NDCA » 08:17
12/01/22
12/01
08:17
12/01/22
08:17
VPLM

Voip-Pal.com

/

+

VoIP-Pal.com announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Carrick Therapeutics receives $35M investment from Pfizer » 08:17
12/01/22
12/01
08:17
12/01/22
08:17
PFE

Pfizer

$50.08 /

+0.62 (+1.25%)

Carrick Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$50.08 /

+0.62 (+1.25%)

PFE Pfizer
$50.08 /

+0.62 (+1.25%)

11/17/22 Credit Suisse
Pfizer initiated with an Outperform at Credit Suisse
11/15/22 BofA
Moderna price target raised to $182 from $160 at BofA
11/03/22 KeyBanc
Maravai Lifesciences price target lowered to $28 from $35 at KeyBanc
11/02/22 Barclays
Pfizer price target raised to $49 from $44 at Barclays
PFE Pfizer
$50.08 /

+0.62 (+1.25%)

PFE Pfizer
$50.08 /

+0.62 (+1.25%)

PFE Pfizer
$50.08 /

+0.62 (+1.25%)

PFE Pfizer
$50.08 /

+0.62 (+1.25%)

Recommendations
Salesforce price target lowered to $200 from $235 at RBC Capital » 08:17
12/01/22
12/01
08:17
12/01/22
08:17
CRM

Salesforce

$159.94 /

+8.22 (+5.42%)

RBC Capital analyst Rishi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$159.94 /

+8.22 (+5.42%)

CRM Salesforce
$159.94 /

+8.22 (+5.42%)

08:01 Today BMO Capital
Salesforce price target lowered to $172 from $180 at BMO Capital
07:50 Today Canaccord
Salesforce price target lowered to $180 from $215 at Canaccord
07:48 Today Truist
Salesforce price target lowered to $210 from $240 at Truist
07:45 Today Morgan Stanley
Salesforce price target lowered to $250 from $273 at Morgan Stanley
CRM Salesforce
$159.94 /

+8.22 (+5.42%)

CRM Salesforce
$159.94 /

+8.22 (+5.42%)

CRM Salesforce
$159.94 /

+8.22 (+5.42%)

CRM Salesforce
$159.94 /

+8.22 (+5.42%)

Hot Stocks
Otonomo Technologies delivers new fleet product enhancements » 08:16
12/01/22
12/01
08:16
12/01/22
08:16
OTMO

Otonomo Technologies

/

+

Otonomo Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTMO Otonomo Technologies
/

+

OTMO Otonomo Technologies
/

+

11/17/22 B. Riley
Otonomo Technologies price target lowered to $1.50 from $2.50 at B. Riley
08/18/22 B. Riley
Otonomo Technologies price target lowered to $2.50 from $4.50 at B. Riley
06/03/22 Citi
Otonomo Technologies initiated with a Neutral at Citi
05/02/22 B. Riley
Otonomo price target lowered to $4.50 from $7.50 at B. Riley
OTMO Otonomo Technologies
/

+

OTMO Otonomo Technologies
/

+

OTMO Otonomo Technologies
/

+

Hot Stocks
Verses Technologies appoints Karl Friston as chief scientist » 08:16
12/01/22
12/01
08:16
12/01/22
08:16
VRSSF

Verses Technologies

/

+

VERSES Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRSSF Verses Technologies
/

+

Hot Stocks
NLS Pharmaceutics receives notice of allowance for Mazindol patent from USPTO » 08:16
12/01/22
12/01
08:16
12/01/22
08:16
NLSP

NLS Pharmaceutics

/

+

NLS Pharmaceutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NLSP NLS Pharmaceutics
/

+

NLSP NLS Pharmaceutics
/

+

11/08/22 Maxim
NLS Pharmaceutics downgraded to Hold from Buy at Maxim
09/06/22 Laidlaw
NLS Pharmaceutics initiated with a Buy at Laidlaw
07/05/22 Alliance Global Partners
NLS Pharmaceutics initiated with a Buy at Alliance Global Partners
Recommendations
Costco price target lowered to $600 from $605 at BofA » 08:15
12/01/22
12/01
08:15
12/01/22
08:15
COST

Costco

$539.05 /

+10.035 (+1.90%)

BofA analyst Robert Ohmes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COST Costco
$539.05 /

+10.035 (+1.90%)

COST Costco
$539.05 /

+10.035 (+1.90%)

07:53 Today Oppenheimer
Oppenheimer removes Costco 'top pick status' on weakened comps
11/29/22 Deutsche Bank
Costco price target lowered to $578 from $581 at Deutsche Bank
11/22/22 BofA
Costco and Cisco added to 'US 1 List' at BofA, Everest Re removed
11/16/22 Evercore ISI
Walmart price target raised to $140 from $135 at Evercore ISI
COST Costco
$539.05 /

+10.035 (+1.90%)

COST Costco
$539.05 /

+10.035 (+1.90%)

COST Costco
$539.05 /

+10.035 (+1.90%)

COST Costco
$539.05 /

+10.035 (+1.90%)

Hot Stocks
Midwest Energy Emissions announces another technology license agreement » 08:15
12/01/22
12/01
08:15
12/01/22
08:15
MEEC

Midwest Energy Emissions

/

+

Midwest Energy Emissions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEEC Midwest Energy Emissions
/

+

MEEC Midwest Energy Emissions
/

+

Hot Stocks
Vaxart announces collaborative funding for study on Novovirus vaccine candidate » 08:14
12/01/22
12/01
08:14
12/01/22
08:14
VXRT

Vaxart

$1.19 /

-0.06 (-4.80%)

Vaxart announced it will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VXRT Vaxart
$1.19 /

-0.06 (-4.80%)

VXRT Vaxart
$1.19 /

-0.06 (-4.80%)

09/02/22 Cantor Fitzgerald
Vaxart price target lowered to $8 from $11 at Cantor Fitzgerald
05/19/22 B. Riley
Vaxart price target lowered to $6 from $7 at B. Riley
02/28/22 Piper Sandler
Piper Sandler 'impressed' by Vaxart's progress in COVID, norovirus programs
01/13/22 Piper Sandler
Vaxart COVID booster on track for first half of the year, says Piper Sandler
VXRT Vaxart
$1.19 /

-0.06 (-4.80%)

VXRT Vaxart
$1.19 /

-0.06 (-4.80%)

Recommendations
Okta price target raised to $69 from $58 at BMO Capital » 08:13
12/01/22
12/01
08:13
12/01/22
08:13
OKTA

Okta

$53.31 /

+2.06 (+4.02%)

, MSFT

Microsoft

$255.13 /

+14.78 (+6.15%)

BMO Capital analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$53.31 /

+2.06 (+4.02%)

MSFT Microsoft
$255.13 /

+14.78 (+6.15%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

08:11 Today DA Davidson
Okta price target raised to $60 from $45 at DA Davidson
07:28 Today Deutsche Bank
Okta price target lowered to $80 from $90 at Deutsche Bank
07:27 Today RBC Capital
Okta price target raised to $80 from $70 at RBC Capital
06:11 Today Oppenheimer
Okta price target lowered to $85 from $95 at Oppenheimer
MSFT Microsoft
$255.13 /

+14.78 (+6.15%)

07:30 Today Wedbush
Activision Blizzard added to Best Ideas List at Wedbush
11/29/22 Morgan Stanley
Microsoft demand should hold up better than investors fear, says Morgan Stanley
11/28/22 JPMorgan
Activision Blizzard price target lowered to $86 from $95 at JPMorgan
11/28/22 Wells Fargo
Wells Fargo upgrades Activision Blizzard to Overweight with $95 price target
OKTA Okta
$53.31 /

+2.06 (+4.02%)

MSFT Microsoft
$255.13 /

+14.78 (+6.15%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

MSFT Microsoft
$255.13 /

+14.78 (+6.15%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

MSFT Microsoft
$255.13 /

+14.78 (+6.15%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

MSFT Microsoft
$255.13 /

+14.78 (+6.15%)

Hot Stocks
BYND Cannasoft files EZ-G patent application to include double faceted condom » 08:13
12/01/22
12/01
08:13
12/01/22
08:13
BCAN

BYND Cannasoft

$5.03 /

+1.3 (+34.85%)

BYND Cannasoft…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCAN BYND Cannasoft
$5.03 /

+1.3 (+34.85%)

Hot Stocks
Splunk announces five-year extension of collaboration agreement with AWS » 08:13
12/01/22
12/01
08:13
12/01/22
08:13
SPLK

Splunk

$77.63 /

+1.685 (+2.22%)

, AMZN

Amazon.com

$96.50 /

+4.1 (+4.44%)

Splunk (SPLK) announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$77.63 /

+1.685 (+2.22%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

SPLK Splunk
$77.63 /

+1.685 (+2.22%)

08:10 Today Piper Sandler
Splunk price target lowered to $105 from $120 at Piper Sandler
07:56 Today Canaccord
Splunk price target lowered to $120 from $130 at Canaccord
07:37 Today Oppenheimer
Splunk price target lowered to $115 from $140 at Oppenheimer
07:28 Today Deutsche Bank
Splunk price target lowered to $90 from $117 at Deutsche Bank
AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

07:39 Today Cowen
Amazon.com price target raised to $160 from $150 at Cowen
11/30/22 JMP Securities
JMP Securities encouraged by Amazon.com's focus on innovation
11/29/22 UBS
Affirm initiated with a Neutral at UBS
11/22/22 Piper Sandler
Amazon.com price target lowered to $119 from $125 at Piper Sandler
SPLK Splunk
$77.63 /

+1.685 (+2.22%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

SPLK Splunk
$77.63 /

+1.685 (+2.22%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

SPLK Splunk
$77.63 /

+1.685 (+2.22%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

SPLK Splunk
$77.63 /

+1.685 (+2.22%)

AMZN Amazon.com
$96.50 /

+4.1 (+4.44%)

Recommendations
Nutanix price target raised to $33 from $29 at Piper Sandler » 08:12
12/01/22
12/01
08:12
12/01/22
08:12
NTNX

Nutanix

/

+

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTNX Nutanix
/

+

NTNX Nutanix
/

+

07:17 Today Wells Fargo
Nutanix price target raised to $32 from $20 at Wells Fargo
10/24/22 KeyBanc
Nutanix price target raised to $33 from $26 at KeyBanc
10/17/22 Needham
Nutanix price target raised to $31 from $25 at Needham
10/11/22 Cleveland Research
Nutanix upgraded to Buy from Neutral at Cleveland Research
NTNX Nutanix
/

+

NTNX Nutanix
/

+

NTNX Nutanix
/

+

NTNX Nutanix
/

+

Downgrade
Parsons downgraded to Underperform at BofA after 'strong re-rating' » 08:12
12/01/22
12/01
08:12
12/01/22
08:12
PSN

Parsons

$49.51 /

+1.12 (+2.31%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSN Parsons
$49.51 /

+1.12 (+2.31%)

PSN Parsons
$49.51 /

+1.12 (+2.31%)

07:55 Today BofA
Parsons downgraded to Underperform from Neutral at BofA
11/03/22 Truist
Parsons price target raised to $50 from $42 at Truist
04/22/22 Truist
Parsons downgraded to Hold from Buy at Truist
03/17/22 Stifel
Parsons resumed with a Buy at Stifel
PSN Parsons
$49.51 /

+1.12 (+2.31%)

Hot Stocks
Mullen Automotive officially closes on acquisition of ELMS assets » 08:12
12/01/22
12/01
08:12
12/01/22
08:12
MULN

Mullen Automotive

/

+

, ELMS

Electric Last Mile Solutions

/

+

Mullen Automotive (MULN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MULN Mullen Automotive
/

+

ELMS Electric Last Mile Solutions
/

+

MULN Mullen Automotive
/

+

ELMS Electric Last Mile Solutions
/

+

02/03/22 Jefferies
Jefferies downgrades Electric Last Mile Solutions, slashes target to $2.50
02/03/22 Benchmark
Electric Last Mile Solutions downgraded to Hold from Buy at Benchmark
02/03/22 Jefferies
Electric Last Mile Solutions downgraded to Hold from Buy at Jefferies
02/02/22 DA Davidson
DA Davidson cuts Electric Last Mile Solutions to Neutral on management exit
MULN Mullen Automotive
/

+

MULN Mullen Automotive
/

+

ELMS Electric Last Mile Solutions
/

+

Hot Stocks
Grom Social's Curiosity Ink Media, Cepia Entertainment partner for Santa.com » 08:12
12/01/22
12/01
08:12
12/01/22
08:12
GROM

Grom Social Enterprises

/

+

Grom Social…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GROM Grom Social Enterprises
/

+

GROM Grom Social Enterprises
/

+

07/26/22 EF Hutton
Grom Social price target lowered to $2 from $5 at EF Hutton
01/13/22 EF Hutton
Grom Social Enterprises initiated with a Buy at EF Hutton
Recommendations
nCino price target lowered to $35 from $38 at Piper Sandler » 08:11
12/01/22
12/01
08:11
12/01/22
08:11
NCNO

nCino

$26.11 /

+1.16 (+4.65%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCNO nCino
$26.11 /

+1.16 (+4.65%)

NCNO nCino
$26.11 /

+1.16 (+4.65%)

07:25 Today KeyBanc
nCino price target lowered to $30 from $35 at KeyBanc
07:23 Today Barclays
nCino price target lowered to $35 from $39 at Barclays
11/02/22 Macquarie
nCino transferred with Outperform rating at Macquarie
10/31/22 Scotiabank
nCino initiated with an Outperform at Scotiabank
NCNO nCino
$26.11 /

+1.16 (+4.65%)

NCNO nCino
$26.11 /

+1.16 (+4.65%)

NCNO nCino
$26.11 /

+1.16 (+4.65%)

Recommendations
Okta price target raised to $60 from $45 at DA Davidson » 08:11
12/01/22
12/01
08:11
12/01/22
08:11
OKTA

Okta

$53.31 /

+2.06 (+4.02%)

DA Davidson analyst Rudy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

07:28 Today Deutsche Bank
Okta price target lowered to $80 from $90 at Deutsche Bank
07:27 Today RBC Capital
Okta price target raised to $80 from $70 at RBC Capital
06:11 Today Oppenheimer
Okta price target lowered to $85 from $95 at Oppenheimer
11/29/22 Jefferies
Okta risk/reward attractive amid low expectations, says Jefferies
OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

OKTA Okta
$53.31 /

+2.06 (+4.02%)

Hot Stocks
Cidara Therapeutics announces issuance of first U.S. patent for CD388 » 08:10
12/01/22
12/01
08:10
12/01/22
08:10
CDTX

Cidara Therapeutics

/

+

, JNJ

Johnson & Johnson

$177.94 /

+1.895 (+1.08%)

Cidara Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDTX Cidara Therapeutics
/

+

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

CDTX Cidara Therapeutics
/

+

05/12/22 H.C. Wainwright
Cidara Therapeutics price target lowered to $6 from $7.50 at H.C. Wainwright
12/03/21 H.C. Wainwright
Cidara Therapeutics assumed with a Buy at H.C. Wainwright
JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
11/17/22 Credit Suisse
Johnson & Johnson initiated with a Neutral at Credit Suisse
CDTX Cidara Therapeutics
/

+

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

Recommendations
Splunk price target lowered to $105 from $120 at Piper Sandler » 08:10
12/01/22
12/01
08:10
12/01/22
08:10
SPLK

Splunk

$77.63 /

+1.685 (+2.22%)

Piper Sandler analyst Rob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$77.63 /

+1.685 (+2.22%)

SPLK Splunk
$77.63 /

+1.685 (+2.22%)

07:56 Today Canaccord
Splunk price target lowered to $120 from $130 at Canaccord
07:37 Today Oppenheimer
Splunk price target lowered to $115 from $140 at Oppenheimer
07:28 Today Deutsche Bank
Splunk price target lowered to $90 from $117 at Deutsche Bank
07:13 Today RBC Capital
Splunk price target raised to $110 from $105 at RBC Capital
SPLK Splunk
$77.63 /

+1.685 (+2.22%)

SPLK Splunk
$77.63 /

+1.685 (+2.22%)

SPLK Splunk
$77.63 /

+1.685 (+2.22%)

SPLK Splunk
$77.63 /

+1.685 (+2.22%)

Hot Stocks
Integra LifeSciences plans $150M share repurchase » 08:10
12/01/22
12/01
08:10
12/01/22
08:10
IART

Integra LifeSciences

$54.88 /

+1.21 (+2.25%)

The company is planning a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IART Integra LifeSciences
$54.88 /

+1.21 (+2.25%)

IART Integra LifeSciences
$54.88 /

+1.21 (+2.25%)

10/27/22 JMP Securities
Integra LifeSciences price target lowered to $75 from $85 at JMP Securities
10/26/22 Piper Sandler
Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem
10/17/22 Truist
Integra LifeSciences price target lowered to $46 from $60 at Truist
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
IART Integra LifeSciences
$54.88 /

+1.21 (+2.25%)

IART Integra LifeSciences
$54.88 /

+1.21 (+2.25%)

Hot Stocks
Integra LifeSciences to acquire Surgical Innovation Associates for $50M upfront » 08:09
12/01/22
12/01
08:09
12/01/22
08:09
IART

Integra LifeSciences

$54.88 /

+1.21 (+2.25%)

Integra LifeSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IART Integra LifeSciences
$54.88 /

+1.21 (+2.25%)

IART Integra LifeSciences
$54.88 /

+1.21 (+2.25%)

10/27/22 JMP Securities
Integra LifeSciences price target lowered to $75 from $85 at JMP Securities
10/26/22 Piper Sandler
Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem
10/17/22 Truist
Integra LifeSciences price target lowered to $46 from $60 at Truist
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
IART Integra LifeSciences
$54.88 /

+1.21 (+2.25%)

IART Integra LifeSciences
$54.88 /

+1.21 (+2.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.